Pfizer and BioNTech Announce Omicron-Adapted COVID-19 Vaccine Candidates Demonstrate High Immune Response Against Omicron
NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Jun 25, 2022--
NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Jun 25, 2022--